MX374489B - Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas, y método de preparación de la misma. - Google Patents
Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas, y método de preparación de la misma.Info
- Publication number
- MX374489B MX374489B MX2016001238A MX2016001238A MX374489B MX 374489 B MX374489 B MX 374489B MX 2016001238 A MX2016001238 A MX 2016001238A MX 2016001238 A MX2016001238 A MX 2016001238A MX 374489 B MX374489 B MX 374489B
- Authority
- MX
- Mexico
- Prior art keywords
- formulation
- platelets
- blood composition
- growth factors
- proteins
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- 239000008280 blood Substances 0.000 title abstract 4
- 210000004369 blood Anatomy 0.000 title abstract 4
- 238000009472 formulation Methods 0.000 title abstract 4
- 239000003102 growth factor Substances 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 230000004071 biological effect Effects 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3616—Blood, e.g. platelet-rich plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una formulación que comprende o se deriva de una composición sanguínea inicial rica en plaquetas y/o factores de crecimiento y proteínas provenientes de la propia composición sanguínea inicial, donde dichas proteínas se encuentran en estado gelificado. Se reivindica asimismo un método de preparación de dicha formulación, que comprende los pasos de calentar y posteriormente enfriar la composición sanguínea inicial a unas determinadas temperaturas y tiempos. Entre otras ventajas, la formulación según la invención es biocompatible y biodegradable, presenta las propiedades biológicas o médicas deseables proporcionadas por la presencia de plaquetas o factores de crecimiento, y además presenta una elevada estabilidad dimensional a lo largo del tiempo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201300718A ES2527967B1 (es) | 2013-08-01 | 2013-08-01 | Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas y método de preparación de la misma |
| PCT/ES2014/070623 WO2015015037A1 (es) | 2013-08-01 | 2014-07-31 | Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas, y método de preparación de la misma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016001238A MX2016001238A (es) | 2016-05-24 |
| MX374489B true MX374489B (es) | 2025-03-06 |
Family
ID=51422102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016001238A MX374489B (es) | 2013-08-01 | 2014-07-31 | Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas, y método de preparación de la misma. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9861684B2 (es) |
| EP (1) | EP3028710B1 (es) |
| JP (1) | JP6466443B2 (es) |
| KR (1) | KR20160036557A (es) |
| CN (1) | CN105431155B (es) |
| AR (1) | AR097176A1 (es) |
| BR (1) | BR112015031733A2 (es) |
| CA (1) | CA2919314C (es) |
| CL (1) | CL2015003579A1 (es) |
| ES (2) | ES2527967B1 (es) |
| MX (1) | MX374489B (es) |
| PE (1) | PE20160014A1 (es) |
| PL (1) | PL3028710T3 (es) |
| PT (1) | PT3028710T (es) |
| RU (1) | RU2697249C2 (es) |
| TW (1) | TWI684454B (es) |
| WO (1) | WO2015015037A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6999927B2 (ja) * | 2017-11-13 | 2022-01-19 | 株式会社細胞応用技術研究所 | 多血小板血漿を製造する方法 |
| WO2019151205A1 (ja) | 2018-01-30 | 2019-08-08 | 富士フイルム株式会社 | フィブリン組成物、再生医療用基材、フィブリン組成物の製造方法およびキット |
| ES2778798B2 (es) * | 2019-02-11 | 2021-10-13 | Biotechnology Inst I Mas D Sl | Formulacion o adhesivo tisular obtenida de una composicion sanguinea que contiene plaquetas, y metodo de preparacion de dicha formulacion |
| ES2782723B2 (es) * | 2019-03-13 | 2021-05-18 | Active Bioregeneration Tech Sl | Procedimiento para obtencion y conservacion de factores de crecimiento de alta pureza y sus usos |
| IT201900006867A1 (it) * | 2019-05-15 | 2020-11-15 | Prometheus Soc A Responsabilita Limitata | Metodo e dispositivo di realizzazione di una composizione comprendente plasma arricchito di piastrine, un kit per detto dispositivo di realizzazione, detta composizione stessa e uso di detta composizione |
| RU2755347C1 (ru) * | 2020-12-11 | 2021-09-15 | Денис Григорьевич Кайгородов | Композиция для коррекции возрастных изменений кожи и способ ее получения |
| CN115531592A (zh) * | 2022-10-27 | 2022-12-30 | 李升红 | 一种实现皮肤高效修复的皮肤敷料及其制备方法 |
| CN119454583B (zh) * | 2025-01-15 | 2025-05-23 | 中南大学湘雅医院 | 一种用于治疗宫腔粘连的温敏型可降解凝胶及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR022333A1 (es) * | 1999-01-26 | 2002-09-04 | Anitua Aldecoa Eduardo | Regenerador de tejido oseo |
| US7015198B1 (en) * | 1999-05-11 | 2006-03-21 | Orentreich Foundation For The Advancement Of Science, Inc. | Materials for soft tissue augmentation and methods of making and using same |
| US8389687B2 (en) * | 2000-10-23 | 2013-03-05 | Shanbrom Technologies, Llc | Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors |
| ES2221770B2 (es) | 2002-04-19 | 2006-07-16 | Eduardo Anitua Aldecoa | Metodo de preparacion de un compuesto para la regeneracion de tejidos. |
| ES2539515T3 (es) * | 2006-07-21 | 2015-07-01 | Genera Istrazivanja D.O.O. | Dispositivo de coágulo derivado de sangre entera para el tratamiento de defectos óseos |
| ES2333498B1 (es) * | 2007-08-02 | 2011-01-10 | Biotechnology Institute, I Mas D, S.L. | Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto. |
| WO2010142784A2 (en) * | 2009-06-11 | 2010-12-16 | Universitat Autònoma De Barcelona | Use of gelled prp (platelet gel) for volumetric breast reconstruction |
| WO2011150328A1 (en) * | 2010-05-27 | 2011-12-01 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Wet-electrospun biodegradable scaffold and uses therefor |
| ES2369945B1 (es) * | 2011-07-29 | 2012-10-15 | Eduardo Anitua Aldecoa | Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento. |
-
2013
- 2013-08-01 ES ES201300718A patent/ES2527967B1/es active Active
-
2014
- 2014-07-29 TW TW103125833A patent/TWI684454B/zh not_active IP Right Cessation
- 2014-07-31 EP EP14756084.1A patent/EP3028710B1/en active Active
- 2014-07-31 AR ARP140102877A patent/AR097176A1/es unknown
- 2014-07-31 WO PCT/ES2014/070623 patent/WO2015015037A1/es not_active Ceased
- 2014-07-31 PL PL14756084T patent/PL3028710T3/pl unknown
- 2014-07-31 KR KR1020167001591A patent/KR20160036557A/ko not_active Abandoned
- 2014-07-31 US US14/447,853 patent/US9861684B2/en active Active
- 2014-07-31 ES ES14756084T patent/ES2755172T3/es active Active
- 2014-07-31 PT PT147560841T patent/PT3028710T/pt unknown
- 2014-07-31 JP JP2016530556A patent/JP6466443B2/ja active Active
- 2014-07-31 PE PE2015002551A patent/PE20160014A1/es unknown
- 2014-07-31 CA CA2919314A patent/CA2919314C/en active Active
- 2014-07-31 BR BR112015031733A patent/BR112015031733A2/pt active Search and Examination
- 2014-07-31 MX MX2016001238A patent/MX374489B/es active IP Right Grant
- 2014-07-31 RU RU2016102768A patent/RU2697249C2/ru active
- 2014-07-31 CN CN201480042878.XA patent/CN105431155B/zh not_active Expired - Fee Related
-
2015
- 2015-12-09 CL CL2015003579A patent/CL2015003579A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112015031733A2 (pt) | 2017-07-25 |
| RU2016102768A3 (es) | 2018-05-14 |
| ES2527967A2 (es) | 2015-02-02 |
| AR097176A1 (es) | 2016-02-24 |
| WO2015015037A1 (es) | 2015-02-05 |
| TWI684454B (zh) | 2020-02-11 |
| US9861684B2 (en) | 2018-01-09 |
| PE20160014A1 (es) | 2016-01-29 |
| ES2527967B1 (es) | 2015-12-28 |
| KR20160036557A (ko) | 2016-04-04 |
| EP3028710A1 (en) | 2016-06-08 |
| JP2016528225A (ja) | 2016-09-15 |
| RU2697249C2 (ru) | 2019-08-13 |
| JP6466443B2 (ja) | 2019-02-06 |
| ES2755172T3 (es) | 2020-04-21 |
| CL2015003579A1 (es) | 2016-06-10 |
| CA2919314C (en) | 2023-02-21 |
| RU2016102768A (ru) | 2017-09-06 |
| CN105431155A (zh) | 2016-03-23 |
| ES2527967R1 (es) | 2015-03-09 |
| US20150037430A1 (en) | 2015-02-05 |
| PL3028710T3 (pl) | 2020-02-28 |
| PT3028710T (pt) | 2019-10-31 |
| CA2919314A1 (en) | 2015-02-05 |
| EP3028710B1 (en) | 2019-09-04 |
| CN105431155B (zh) | 2020-07-28 |
| MX2016001238A (es) | 2016-05-24 |
| TW201536299A (zh) | 2015-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX374489B (es) | Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas, y método de preparación de la misma. | |
| CO2019006860A2 (es) | Composiciones de silicona rápidamente reticulables a temperaturas ambiente y métodos para fabricarlas y usarlas | |
| MX2022015631A (es) | Anticuerpos anti-cd40 humanizados y usos de los mismos. | |
| EA201992155A1 (ru) | Способы криогенного хранения | |
| BR112017010074A2 (pt) | preenchimento dérmico a base de ácido hialurônico reticulado e lubrificante de carboximetilcelulose | |
| EP4477662A3 (en) | Nucleic acid molecules and uses thereof | |
| MX390739B (es) | Composicion de hueso comprimido y metodo para usar la misma. | |
| BR112016023304A2 (pt) | célula hospedeira recombinante engendrada para superexpressar proteínas auxiliares | |
| BR112017001456A2 (pt) | sistemas de prótese provisória e métodos de utilização dos mesmos | |
| SG10201906859PA (en) | Novel proteins specific for angiogenesis | |
| BR112015017069A2 (pt) | processo para preparação de extrato a partir de meio de cultura de ceriporialacerata e composições farmacêuticas preparadas pelo que para prevenção ou tratamento de doenças diabéticas e complicações diabéticas, que contêm extrato de meio de cultura de ceriporialacerata como ingrediente ativo | |
| BR112016004510A2 (pt) | composições bioativas deriváveis de concentrados de plaquetas e métodos para preparar e usar as mesmas | |
| MX2016008442A (es) | Formulacion de factor de crecimiento de fibroblastos 18 en hidrogeles de alginato/colageno. | |
| BR112017001550A2 (pt) | enxerto de tecido | |
| MX2020003052A (es) | Composiciones y metodos para inactivacion de patogenos de plaquetas. | |
| MX2019014397A (es) | Polipeptidos que enlazan adamts5, mmp13 y agrecano. | |
| EA201891577A1 (ru) | Системы и способы для приготовления тромбоцитов | |
| ZA202100888B (en) | Methods of preparing personalized blood vessels | |
| EA201691699A1 (ru) | Производство йогурта | |
| CL2011001870A1 (es) | Proceso de preparacion de un gel de fibrina autologo o desde sangre compatible para proliferacion y vehiculizacion celular; gel de fibrina o de sangre compatible; uso del gel de fibrina o de sangre compatible para uso quirurgico. | |
| LT2013104A (lt) | Granuliocitų kolonijas stimuliuojančio faktoriaus sulieti baltymai su kitais augimo faktoriais, optimaliai su kamieninių ląstelių faktoriumi, ir jų gavimo būdas | |
| MX2019006783A (es) | Procedimiento para la preparacion de 4-amino-1-( (1s, 4r, 5s) -2-fluoro-4,5-dihidroxi-3-hidroximetil-ciclopent-2-enil)-1h-pirim idin-2-ona. | |
| MX2015010163A (es) | Bionanoparticulas biodegradables para liberacion del peptido gse24-2, procedimiento de obtencion y utilizacion. | |
| GB2528406A (en) | Prebiotic composition and method of its use | |
| Kamolz et al. | Skin substitutes: which one do we know, which one do we use? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |